References
- Sandoval LF, Pierce A, Feldman SR. Systemic therapies for psoriasis: an evidence-based update. Am J Clin Dermatol. 2014;15:165–80.
- Ortendahl M. Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manag. 2007;3:1175–80.
- Rosen AB, Tsai JS, Downs SM. Variations in risk attitude across race, gender, and education. Med Decis Mak. 2003;23:511–17.
- Bergus GR, Levin IP, Elstein AS. Presenting risks and benefits to patients. J Gen Intern Med. 2002;17:612–17.
- Lis K, Kuzawińska O, Bałkowiec-Iskra E. State of the art paper tumor necrosis factor inhibitors – state of knowledge. Arch Med Sci. 2014;6:1175–85.
- Saleem MD, Kesty C, Feldman SR. Relative versus absolute risk of comorbidities in patients with psoriasis. J Am Acad Dermatol. 2016:1–7.